Clinical Trial Update: Evaluation of the Efficacy and Safety of Two Ibuprofen Combination Products for the Treatment of the Common Cold and Flu in Latin America [Phase 3]

View source ↗

Summary

Pfizer withdrew a Phase 3 trial evaluating two ibuprofen combination products for the treatment of the common cold and influenza in Latin America.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Common Cold

Drugs mentioned

• Ibuprofen combination product 1
• Ibuprofen combination product 2

Snippet

Sponsor: Pfizer | Conditions: Common Cold | Phase 3 | Status: WITHDRAWN